The present invention relates to novel cyclic or constrained acyclic compounds which modulate the activity of G protein-coupled receptors and are useful in the treatment of conditions mediated by G protein-coupled receptors, for example, inflammatory conditions.

 
Web www.patentalert.com

< Method to input and store data for a clinical study

< Diaphragm and speaker

> RFID wireless 2G, 3G, 4G internet systems including Wi-Fi, Wi-Max, OFDM, CDMA, TDMA, GSM

> Photonic crystal sensors with intergrated fluid containment structure
~ 00601